Glenmark Gets Early Win In Challenge To Merck's Zetia Patent Claims
This article was originally published in PharmAsia News
Executive Summary
India's Glenmark Phrmaceuticals has won a favorable decision in a U.S. court against Merck and its patents on Zetia (ezetimibe) for controlling cholesterol